Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer

NCT04355858 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

319

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Cancer

Interventions

DRUG: SHR7390
DRUG: Famitinib
DRUG: SHR3162
DRUG: Pyrotinib
DRUG: Capecitabine
DRUG: SHR1210
DRUG: Everolimus
DRUG: Nab paclitaxel
DRUG: SHR2554
DRUG: SHR3680
DRUG: SHR6390
DRUG: SHR1701
DRUG: SERD
DRUG: AI
DRUG: VEGFi

Sponsor

Fudan University